During the past decade, Service de Pneumologie conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Service de Pneumologie" #1 sponsor was "Rennes University Hospital" with 2 trials, followed by "University Hospital, Limoges" with 2 trials sponsored, "Central Hospital, Nancy, France" with 1 trials sponsored, "Centre Hospitalier Universitaire de Nīmes" with 1 trials sponsored and "Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Service de Pneumologie" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator, "Groupe Français de Pneumologie Cancérologie (GFPC)" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Service de Pneumologie" are "Advanced Non Small Cell Lung Cancer" (1 trials), "Critical Illness" (1 trials), "HIV Risk" (1 trials), "Non Small Cell Lung Cancer" (1 trials) and "Non Small Cell Lung Carcinoma" (1 trials). Many other conditions were trialed in "Service de Pneumologie" in a lesser frequency.

Most popular intervention types in "Service de Pneumologie" are "Drug" (4 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Chemotherapy" (1 trials), "Docetaxel" (1 trials), "Dual-agent therapy or docetaxel alone or best supportive care" (1 trials), "Erlotinib + docetaxel" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Service de Pneumologie" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Service de Pneumologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Service de Pneumologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Service de Pneumologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Service de Pneumologie has several departments that took part in Clinical trials: "Service de Pneumologie ; Centre hospitalier" - 2 trials